Skip to main content
Clinical Trials/NCT01911286
NCT01911286
Completed
Not Applicable

Comparison of Two Strategies to Realize Apnea Test for the Diagnostic of Brain in Potentiel Organ Donors.

Poitiers University Hospital17 sites in 1 country208 target enrollmentJuly 2013

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Alternative Method of Apnea Test
Sponsor
Poitiers University Hospital
Enrollment
208
Locations
17
Primary Endpoint
Eligibility to lung harvest
Status
Completed
Last Updated
9 years ago

Overview

Brief Summary

Clinical diagnostic of brain death requires a non-reactive coma, absence of brain stem reflex, and absence of spontaneous breathing. The confirmation of absence of spontaneous breathing is established the apnea test (according to the American Academy of Neurology's Guidelines). However this test may lead to complications (acute hypoxemia, ventilatory and cardiocirculatory disorders) and reduces significantly the number of lung transplants. Some data suggest modifying the apnea test : replace the ventilator switching off with continuous positive airway pressure (CPAP) use. These studies showed that this alternative method (CPAP) increased the level of lung harvest but they were not sufficient because these studies were monocentric with little patients,. That why the aim of the present study is to compare the standard strategy and CPAP strategy with a prospective, multicenter,cluster trial; each center will use the method of apnea test which it uses usually.

Registry
clinicaltrials.gov
Start Date
July 2013
End Date
December 2015
Last Updated
9 years ago
Study Type
Observational
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Age : from 18 to 75 years
  • Neurological signs evoking cerebral ischemia

Exclusion Criteria

  • Severe hypoxemia (PaO2/FiO2 \< 200) with controlled ventilation (FiO2: 100%)
  • Hypothermia \< 36°C
  • Obesity (BMI ≥ 40) with documented hypopnoea
  • Intractable hypotension despite optimal filling and catecholamine doses \> 1µg.Kg.min
  • Patients with contraindication for organs harvesting.
  • Documented chronic respiratory failure
  • Progressive infectious acute respiratory disease
  • Family opposition to subject's participation in the study

Outcomes

Primary Outcomes

Eligibility to lung harvest

Time Frame: 2 years

Secondary Outcomes

  • Rate of apnea test interruption(2 years)
  • Number of lung transplantation realization(2 years)
  • Levels of hypoxemia(2 years)
  • Rate of cardiocirculatory impairment(2 years)
  • Arterial blood gas after apnea test(2 years)
  • Rate of ventilatory impairment(2 years)

Study Sites (17)

Loading locations...

Similar Trials